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Conclusions: Aggressive repair of accompanying TR should be undertaken
at the time of initial mitral surgery. Tricuspid valve repair, described by De
Vega, is a simple, short, and inexpensive procedure with few complications.
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Objectives: What influence do patient selection and learning curve have on
the results of transapical aortic valve implantation (TAVI)?
Methods: From September 2007 to January 2009, 33 patients treated with
TAVI for severe symptomatic aortic stenosis were included in a prospective
registry. According to their risk profile, 2 patient groups were distinguished.
In Group 1 (n=25) the high surgical risk was related to technical difficulties
for conventional aortic valve replacement (porcelain aorta, redo surgery with
patent coronary artery bypass grafts, hi-dose mediastinal radiotherapy). In
Group 2 (n=8) the high risk was due to severe comorbidities.
Results: TAVI was successfully performed in all patients without per-pro-
cedural death or stroke. “Valve in valve” reimplantation was necessary in 2
patients due to persistent leaks. Mean follow-up was 10.8 months (1-17).
Overall mortality was 16% in Group 1and 37.5% in Group 2 (p=0.03). Predic-
tive factors of hospital mortality were: NYHA class (p=0.03), LV dysfunction
(p=0.009) and pulmonary hypertension (p<0.001). No reintervention, pros-
thetic valve deterioration or haemolysis was recorded. In-hospital mortality
decreased from 15.2% in the first 17 patients to 6.1% in the last 16 patients
implanted.
Conclusions: TAVI gives superior results in patients with technical diffi-
culties for conventional surgery than in patients with severe comorbidities.
These results could be improved by accumulating experience and better patient
selection.
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Objective: Risk assessment for patients undergoing transapical aortic valve
implantation (TAVI) is currently performed with the EuroSCORE and STS-
PROM risk algorithms. None of these scores were designed for a TAVI pop-
ulation. To demonstrate their accuracy, both scores were compared to the real
outcome in patients undergoing TAVI.
Methods: 33 patients underwent TAVI using the Edwards Sapien biopros-
thesis between September 2007, and April 2009 due to contraindications of
conventional surgery and/or high operative risk. Mean age was 81 ± 9.8 Years,
and 40% were female. Mean STS and EuroSCORE were 21% and 28.6%,
respectively.
Multiple variables were used in the calculation of the EuroScore and the
STS-PROM algorithms including chronic lung disease (24%), renal Failure
(36.4%), cancer (27.3%), neurological dysfunction (12%), peripheral arteriop-
athy (69.7%), previous cardiac surgery (42.4%), Diabetes (30%), severe pul-
monary hypertension ≥ 60 mmHg (18.2%), moderate LV dysfunction EF≤50%
(54.6%), and LVEF ≤ 30% (21.2%). Certain variables do not figure in the
algorithm as porcelain aorta (39.4 %) and mediastinal irradiation (6%).
Observed in-hospital death was 18.2%. The actual and predicted mortality
were compared.
Results: Operative mortality (30 days) = 5 patients (15.6 %). An additional
4 patients (12.1 %) died during the follow-up study period of 587days (mean
324 ± 164). Overall mortality = 9 patients (27.3 %). Both the STS and Euro-
SCORE failed to demonstrate significant correlation with predicted operative
mortality (p=0.145 and 0.875, respectively). The STS algorithm seems more
accurate in estimating the operative mortality in TAVI patients.
Conclusion: Current surgical scores correlate poorly with the observed
outcome. Refining these scores for high risk patients requiring aortic valve
surgery may improve patient selection for TAVI.
